NRL for DNA Diagnostics
The main areas of the NRL include molecular-genetic diagnostics, monitoring of oncohematologic diseases and HLA typing for transplantation of hematopoietic stem cells.
For these purposes, the NRL provides reference samples and material and evaluates results of other laboratories in accordance with international standards.
The laboratory also provides consultant services and organizes conferences, seminars and workshops.
Our working groups organize external proficiency testing (EPT) for several examinations. The NRL also participates in a wide range of research projects and educational activities.
Since 2002, the NRL for DNA Diagnostics has been accredited by the Czech Institute for Accreditation as a testing laboratory number 1345 (according to the Czech version of the European Standard EN ISO/IEC 17025 Conformity assessment – General requirements for the competence of testing and calibration laboratories) for molecular genetic analysis of human genome using PCR methods (see the list below).
In 2004, the NRL for DNA Diagnostics was accredited by the Czech Institute for Accreditation as the first medical laboratory number M8001 according to CSN EN ISO 15189. Since November 1st 2015 all examinations have been provided as a part of the IHBT Lab Complex and the activity of the NRL as an accredited medical laboratory was finished.
Form for Laboratory Assessment (only in Czech).
Working groups and organized determinations:
Department of Molecular Genetics
Head of the Department: Mgr. Machová Poláková Kateřina, Ph.D.
Deputy Head of the Department: Mgr. Hana Žižková, Ph.D.
Accredited determinations:
- Determination of BCR-ABL fusion gene rearrangements using multiplex RT PCR
(NRL_03_SOP_14_02) - Determination of BCR-ABL transcript level using real-time RT PCR
(NRL_04_SOP_14_02/procedure A) - Determination of BCR-ABL kinase domain mutation using direct sequencing
(NRL_04_SOP_14_02/procedure B) - Determination of the conversion factor for expressing the results of BCR-ABL transcript level in international scale
(NRL_04_SOP_14_02/procedure C)
Department of HLA
Head of the Department: Ing. Milena Vrana
Department of Cell Chimerism
Department head: Mgr. Lucie Stefflová
Technical head: RNDr. Radka Žižková
Genotyping of sequence polymorphisms is used to identify the cell population (procedure A) and possibly followed by quantitative determination of individual cell populations contained in the sample (procedure B). For identification and quantification, short tandem repeats (STR) polymorphisms and short insertions and deletions (indels) polymorphisms are used.
The department of cell chimerism organizes the External Proficiency Testing for Quantitative Analysis of Cell Chimerism after Allogeneic HSCT annually and at the international level.
Accredited determinations:
-
Genotyping of sequence polymorphisms by electrophoresis using commercial kits
(NRL_01_SOP_14_02/ procedure A) -
The assessment of the quantitative representation of genotypes in the sample of sequence polymorphisms by electrophoresis using commercial kits
(NRL_01_SOP_14_02, procedure B) -
Genotyping of sequence polymorphisms by real-time PCR
(NRL_07_SOP_14_02, procedure A) -
The assessment of the quantitative representation of genotypes in the sample of sequence polymorphisms by real-time PCR
(NRL_07_SOP_14_02, procedure B)